MA02.06 Efficacy and Safety of 1L Olomorasib Plus Pembrolizumab in KRAS G12C-Mutant NSCLC: Results From LOXO-RAS-20001 and SUNRAY-01
2025 · Journal of Thoracic Oncology · 1 citations
https://doi.org/10.1016/j.jtho.2025.09.109
Asklepios(DE)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
2
Citations
1
h-index
0
i10-index
N. Reinmuth is an academic researcher from Asklepios. The author has contributed to research in topics: Lung Cancer Research Studies & Nanoparticle-Based Drug Delivery & Cancer Immunotherapy and Biomarkers. The author has an h-index of 1, co-authored 4 publications.
https://doi.org/10.1016/j.jtho.2025.09.109
https://doi.org/10.1016/s1556-0864(25)00491-5
Click to start Chat